Alice I. Marcy

1.1k citations
11 papers · 815 indexed · h-index 10
Topics
Peptidase Inhibition and Analysis (4 papers)Signaling Pathways in Disease (3 papers)Protease and Inhibitor Mechanisms (3 papers)
Partner nations
United States

In The Last Decade

Alice I. Marcy

11 papers receiving 772 citations

Peers

Alice I. Marcy
Comparison fields: 5 of 75
  • Molecular Biology 527
  • Cancer Research 384
  • Oncology 381
  • Hematology 122
  • Organic Chemistry 55
Replace Luke H. Stockwin with:
Luke H. Stockwin United States
Sengodagounder Arumugam United States
John W. Blankenship United States
Chuanbing Bian China
Jack H. Lai United States
Didier Belorgey United Kingdom
Shehab Ismail United Kingdom
Steven P. Leytus United States
Lawrence MacPherson United States
Ahamed Saleem United States
Alice I. Marcy relative to Luke H. Stockwin United States Luke H. Stockwin's profile →
Citations per field
00.5×3.2×
Luke H. Stockwin · 1×
Citations per year

Countries citing papers authored by Alice I. Marcy

Since Specialization
Citations

This map shows the geographic impact of Alice I. Marcy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alice I. Marcy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alice I. Marcy more than expected).

Fields of papers citing papers by Alice I. Marcy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alice I. Marcy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alice I. Marcy. The network helps show where Alice I. Marcy may publish in the future.

Co-authorship network of co-authors of Alice I. Marcy

This figure shows the co-authorship network connecting the top 25 collaborators of Alice I. Marcy. A scholar is included among the top collaborators of Alice I. Marcy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alice I. Marcy. Alice I. Marcy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 17
2 26
3 96
4 7
5 122
6 223
7 122
8 43
9 66
10 82
11 11

About Alice I. Marcy

Alice I. Marcy is a scholar working on Cancer Research, Oncology and Microbiology, having authored 11 papers that have together received 815 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (4 papers), Signaling Pathways in Disease (3 papers) and Protease and Inhibitor Mechanisms (3 papers). The work is most often cited by research in Cancer Research (384 citations), Oncology (381 citations) and Hematology (122 citations). Alice I. Marcy has collaborated with scholars based in United States. Frequent co-authors include Jeffrey D. Hermes, William K. Hagmann, Patricia M. Cameron, James P. Springer, Craig K. Esser, Gregory J. Wiederrecht, A.P. Timerman, Sidney Fleischer, Scott P. Salowe and Paula M.D. Fitzgerald. Their work appears in journals such as Journal of Biological Chemistry, Biochemistry and Analytical Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026